Cochrane

The Cochrane Navarre Associate Centre is at the forefront of advancing evidence-based healthcare in Spain. 💪 Established in 2015, this Centre is a cornerstone in the region, driven by a formal agreement between the Health Department of the Government of Navarre and Iberoamerican Cochrane Center. 🎤 Juan Erviti, Director of the Navarre Associate Centre, highlights the Centre's commitment to rigorous research and knowledge translation: "Our work is deeply rooted in the belief that healthcare decisions should be guided by the best available evidence. By providing training on systematic reviews, GRADE, and critical appraisal, we empower healthcare professionals across Spain to make informed decisions that ultimately improve patient outcomes." 🌍 The Centre plays a vital role within the newly formed Cochrane Heart, Stroke, and Circulation thematic group and the Spanish network for the Improvement of the Appropriateness of Clinical Practice (MAPAC). Their work directly influences clinical guidelines and legally binding resolutions in Navarre, ensuring evidence-based practice across the healthcare system. 🎤 Luis Carlos Saiz, Managing Editor of the Spanish satellite of the Cochrane Hypertension Group, underscores the importance of collaboration in amplifying the Centre’s impact: "Our involvement in networks like MAPAC and the Spanish Medicines Agency’s BIFAP database allows us to work closely with clinicians and researchers, ensuring that our evidence synthesis work is directly applicable to clinical practice. These collaborations are crucial in driving improvements in healthcare delivery." 🤝 The Navarre Associate Centre welcomes collaboration and is eager to expand its network. They invite healthcare professionals and researchers to join them in their mission to enhance evidence-based healthcare! 📖 Read more about their impactful work and how you can get involved: https://lnkd.in/eVmEeUf6 #CochraneIberoamérica #EvidenceBasedHealthcare

Congratulations to Cochrane Malaysia who are celebrating 10 years of impact in 2024! If you are in Malaysia join them for this special event in Bandar Utama on 26 September. The Hon. Minister of Health Malaysia, Datuk Seri Dr Dzulkefly Ahmad will be the guest of honour. The keynote address will be given by Catherine Spencer OBE MBA, Cochrane Chief Executive Officer. Workshops will also be happening for librarians and students. More information and registration: https://lnkd.in/gMRHVAUS 🎉 Join us in celebrating this milestone! A warm congratulations once again to Cchrane Malaysia on 10 years of excellence! 💜 #CochraneMalaysia Jackie Ho

#Volunteer with #CochraneEngage and contribute to better health globally! 🙋♀️ Those who are getting started in #healthresearch can build their skills and experience by applying to volunteer on evidence-based #healthcare evidence tasks, such as translating studies and providing consumer peer reviews. 🤓 More experienced? Use the platform to engage with Cochrane Groups and other organizations, and join Cochrane author teams! 🎖️ Earn 200 Cochrane Membership points for every task you complete on Cochrane Engage! Earning 1000 Cochrane Membership points within 12 months entitles you to Cochrane Membership! ➡️ Browse the listed tasks and create your free Cochrane Engage profile today! https://lnkd.in/gvgVdDmC

Both Cochrane and the Global Evidence Summit are committed to inclusivity and global partnership, with a particular focus on low- and middle-income countries #LMIC. We spoke with Sabrina Khamissa to uncover insights, behind-the-sense information, and updates about the event. 🎤 "GES organizers and the partners involved truly feel that the efforts extend far beyond the confines of a GES single event. By fostering collaboration and knowledge exchange among diverse people, we lay the foundation for sustainable partnerships that transcend geographical boundaries. Ultimately, we aim to empower attendees to take ownership of evidence-based practices, driving positive health outcomes and equity on a global scale." 🤝 We'd like to warmly thank TDR and European & Developing Countries Clinical Trials Partnership for sponsoring people from LMICs who may not have otherwise been able to attend #GES2024 🙌 Read the full interview here: ⬇ https://lnkd.in/gC56N8-k

Daily oral iron supplementation during #pregnancy 📚 🔍 This #SystematicReview included the evidence from 57 trials involving 48,971. Key messages 👍 Women taking daily iron supplements may have reduced #anaemia and iron deficiency when they give birth around their due date, compared with placebo or no iron. 🤷♀️ From the evidence in this review, we are less certain about the impact of iron supplements on other outcomes for the woman and her baby. 🎤 "Iron supplementation during pregnancy may be considered as a preventive strategy to reduce maternal anaemia and iron deficiency at term. The magnitude of the effect may vary depending on the background risk of maternal and infant health outcomes. In order to improve the success of iron supplementation as a #PublicHealth intervention, it is important to consider accessibility to supplementation and adherence." 🤓 Read the full #CochraneReview and #PlainLanguage summary in the#CochraneLibrary https://lnkd.in/gGFpkSd5 Finkelstein JL, Cuthbert A, Weeks J, Venkatramanan S, Larvie DY, De-Regil LM, Garcia-Casal MN. Daily oral iron supplementation during pregnancy. Cochrane Database of Systematic Reviews 2024, Issue 8. Art. No.: CD004736. DOI: 10.1002/14651858.CD004736.pub6.

#CochranePodcast Are #StemCells taken from a person's bone marrow and delivered to their heart a safe and effective treatment following a #HeartAttack? Among the 20 or so Cochrane reviews of treatments for myocardial infarction is one that reached its third update in August 2024. It looks at the effects of stem cells, and we asked new lead author, Peter-Paul Zwetsloot from University Medical Centre Utrecht in the Netherlands to tell us about the importance of the review and the latest findings. 🎧 Listen to the evidence in about 4 minutes https://lnkd.in/gghn7Rap 🤓 Read the #CochraneReview and #PlainLanguage summary https://lnkd.in/gUMMDB8c Zwetsloot PP, van der Naald M, Jones D, Reid A, Chamuleau S, Mathur A. Stem cell treatment for acute myocardial infarction. Cochrane Database of Systematic Reviews 2024, Issue 8. Art. No.: CD006536. DOI: 10.1002/14651858.CD006536.pub5.

Webinar Reminder -- Are you an author or editor looking to improve your Cochrane abstracts? 🤓 Sign-up is open for a free webinar on how to write a Cochrane abstract in the focused review format. ✨ Event: Methods Support Unit Web Clinic 📅 Date: Wednesday, 4th September ⏰ Time: 8am UTC Cochrane abstracts often serve as the primary point of contact for readers. They must stand alone as clear, comprehensible, and easily translatable documents. In this web clinic, Lindsay Robertson will cover the general principles of writing an abstract that is clear, easy to understand, and translate. The specific requirements of the new focused review format and the PRISMA checklist will also be covered. Can't attend live? No problem! All registrants will receive a recording of the session. 👉 Sign up now and ensure your abstracts make an impact!

JUST PUBLISHED - Selective serotonin reuptake inhibitors for premenstrual syndrome #PMS and premenstrual dysphoric disorder 💊 What are selective serotonin reuptake inhibitors? They are a type of medicine that inhibit the absorption of serotonin, a naturally occurring chemical that acts as a messenger between brain cells. Changing the balance of serotonin appears to enhance mood. Selective serotonin reuptake inhibitors are most commonly used to treat depression and anxiety. 📚 🔍 This #SystematicReview included evidence from 34 studies (RCTs) with 4563 women diagnosed with severe premenstrual syndrome or premenstrual dysphoric disorder. Key messages – Selective serotonin reuptake inhibitors treatment probably reduces a woman's rating of premenstrual symptoms and may be more effective when administered continuously than when administered only in the luteal phase (the second part of a menstrual cycle, around day 15 of a 28-day cycle). – Unwanted effects of selective serotonin reuptake inhibitor treatment are probably common; with feeling sick, a lack of energy and having a strong desire to sleep being most often reported. 🚩 We are only moderately confident in the evidence because there was poor reporting of methods in the included studies. In addition, more than two‐thirds of the included studies were funded by pharmaceutical companies, which may mean that the effects look more favourable towards the medicine of the sponsor. This means that results must be interpreted with caution, and further studies are needed to confirm the findings. Jespersen C, Lauritsen MP, Frokjaer VG, Schroll JB. Selective serotonin reuptake inhibitors for premenstrual syndrome and premenstrual dysphoric disorder. Cochrane Database of Systematic Reviews 2024, Issue 8. Art. No.: CD001396. DOI: 10.1002/14651858.CD001396.pub4. 🤓 Read the full #CochraneReview and the #PlainLanguage summary in the #CochraneLibrary https://lnkd.in/gM84MsvP Wong MC, Zhang R, Luo BW, Glenny A-M, Worthington HV, Lo EC. Topical fluoride as a cause of dental fluorosis in children. Cochrane Database of Systematic Reviews 2024, Issue 6. Art. No.: CD007693. DOI: 10.1002/14651858.CD007693.pub3.

#CochranePodcast Alternative ways to organise delivery of health care to older adults living in aged care facilities The Cochrane Library contains several reviews on the effects of different ways of organising and delivering medical care. One of these reviews, published in March 2024, summarises the evidence on models for delivering medical care to older adults living in residential aged care facilities. In this podcast, Liesl Grobler talks with lead author, Polina Putrik, both from Monash University in Melbourne, Australia, about the review. 🎧 Listen to the latest evidence in about 5 minutes https://lnkd.in/eq3thfD2 🤓 Read the full #CochraneRevew and #PlainLanguage summary https://lnkd.in/enZ4cuZ6 Putrik P, Grobler L, Lalor A, Ramsay H, Gorelik A, Karnon J, Parker D, Morgan M, Buchbinder R, O'Connor D. Models for delivery and co‐ordination of primary or secondary health care (or both) to older adults living in aged care facilities. Cochrane Database of Systematic Reviews 2024, Issue 3. Art. No.: CD013880. DOI: 10.1002/14651858.CD013880.pub2

Make sure you check out the #GES2024 programme! Go to https://buff.ly/3PPlRKu Our thanks to our wonderful Programme Partners, who are committed to the Global Evidence Summit theme of ‘Using evidence. Improving lives’ and we value their contributions to the overall scientific programme! AIR Equity Initiative, Institute of Development Studies, Centre for Evidence and Implementation Národní institut kvality a excelence zdravotnictví NIKEZ Cochrane JBI Guidelines International Network The Campbell Collaboration